Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-045972

EVP & Chief Commercial Officer sold 375 shares at $91.53 ($34,324)

From the SEC's structured data for this filing

Trades in this filing

Harris Erik · EVP & Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-07-06 Sale : show line 1 in the form −375 $91.53 $34,324 25,333 D
Open-market sales · 375 sh · avg $91.53 · $34,324
Loading xslF345X03/doc4.xml…